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Available online 2 March 2015A starting point of curating bioinformatic resources for the
public is marked by the establishment of the US National
Center for Biotechnology Information (NCBI) in 1988 [1].
One of its many purposes is certainly to echo the initiative of
the Human Genome Project (HGP) –– when two landmark
reports were published at the same time: ‘‘Mapping and
Sequencing the Human Genome’’ by the National Research
Council [2] and ‘‘Mapping Our Genes –– The Genome
Project: How Big, How Fast?’’ by the US Congress [3].
As HGP is prepared to scale up its sequencing operations
about 5 years into the Project, a new discipline – bioinformat-
ics – became inevitable. It emerged originally for processing
and sharing genome sequences and was thus known as genome
informatics. In the ﬁrst ﬁve-year plan of HGP, it was pointed
out that genome informatics is a scientiﬁc discipline that
encompasses all aspects of genome information acquisition,
processing, storage, distribution, analysis, and interpretation
[4]. This insightful statement was footnoted by the launch of
GenBank at NCBI in 1992, a database of nucleotide
sequences, in collaboration with its international partners at
the European Molecular Biology Laboratory (EMBL) and
the DNA Data Bank of Japan (DDBJ). Now, some 20 years
have passed, not only GenBank still prospers but other data-
bases on human genomics and biology have emerged to ﬁll
up all data landscapes [5].
Genomics together with many other research ﬁelds of life
sciences had entered the Era of Large-scale Data Acquisition
in the early 90’s. The Era was led by the fast accumulationof human genomic sequences and followed by similar data
from other large model organisms [6]. As soon as HGP
declared the human genome sequenced in 2001 [7], the
HapMap Project [8] was announced to sequence hundreds of
human genomes in a diverse population background.
Microbial genomics has also been pursued into both metage-
nomics and pangenomics [9,10]. The big data collection efforts
have been extending all the way into its vertical path –– from
DNA to RNA to Protein [11,12]. Another expansion of the
efforts is horizontally toward biological functions and disease
relevance [13–15]. In order to annotate biological functions at
different levels of anatomy and physiology –– cell, organ, tis-
sue, and systems –– for biomedical applications, data integra-
tion and interpretation become more relevant, and thus the
birth of systems biology, which takes account of data from
all omics ﬁelds and deciphers them in a context of biological
networks. In recent years, with strong funding and rapid devel-
opment, the sequence technology has been advancing signiﬁ-
cantly, resulting in dramatic cost reduction and explosion of
data accumulation. Therefore, a large number of bioinformatic
resources become obvious and there is demand for some com-
prehensive digestions.
There are several data types being curated in bioinformatic
resources world-wide. The ﬁrst of them is classiﬁed as scale-up
omics data, which includes genome-wide data from the vertical
path as mentioned above: genome, transcriptome, proteome,
and metabolome, just to name a few. Each of these data may
have different disease relevance, such as DNA variations for
cancer predisposition and protein structures for drug develop-
ment. The second type of data resources includes data gener-
ated by molecular biologists that tend to look at molecular
details, such as transcription factors and signal transduction
pathways, where interactions among macromolecules andnces and
2 Genomics Proteomics Bioinformatics 13 (2015) 1–3structure–function relationships are highly valued. The third
type of data resources concerns bioinformatic tools (algorithms
and software packages), which include those for sequence
assembly and stitching, gene prediction and annotation, pro-
tein structure prediction, multiple sequence alignment, phy-
logeny, and network analysis. The fourth type is the primary
and secondary literature that contains research papers, mono-
graphs, reviews, conference reports, and even personal websites
and blogs. It also includes publically-available educational
materials, such as training courses, online tutorials, and e-
books. The last, but not the least, refers to web-based gateways
of various institutions, such as research institutes, academic
journals, and topic-focusing websites. All the aforementioned
types of information are mainly stored in a variety of bioinfor-
matic databases, accessible through the internet.
Another characteristic trend of bioinformatic resources is
the increasing bodies of contributors and users from all
ﬁelds of life sciences. First, it calls for more and better
user-friendly tools. In this case, bioinformaticians are held
responsible for building better hubs –– usually containing
databases and toolkits –– for users from the diverse research
ﬁelds. Second, it forces the contributors and users to start
with their own urgent demands and to be innovative for
mining data, providing tools, and understanding information
imbedded in the data. In the meantime, the crowdfunding
activities often lead to resource allocations and thus generate
new ﬁelds or disciplines. Bioinformatics itself is already a
complicated ﬁeld, and its integration and reaching-out to
chemistry efforts have given birth to systems biology and
synthetic biology, respectively. Obviously, the demands com-
ing from medicine and pharmaceutics are composed of
molecular markers for disease diagnostics and prognostics,
as well as drug targets and treatment strategies. The birth
of translational medicine represents a ﬁeld of research seek-
ing medical applications for genomic data. The ultimate goal
of genomic data and bioinformatics is to pave a way for
medicine to be personalized and more precision and thus
the new path –– precision medicine. Other extensions include
applications in a much broader settings, such as environ-
ment, energy, and agriculture. Third, the complexity of the
data and information, as well as the conversion of both into
knowledge, are all seeking for more intensive collaborations
involving experts and talents from relevant disciplines, other
than biologists, such as mathematicians, physicists, chemists,
and computer scientists.
I would like to end this perspective by emphasizing a couple
of the major issues of bioinformatics, encountered over my
career path. On one hand, we still face the same challenge as
the past three decades –– best annotating the large number
of experimental data; one of the examples is non-coding
sequences in the genomes, such as the human genome. There
are at most 3% of the human genomes are ‘‘gene coding’’,
and the rest is classiﬁed as non-coding, sometimes the ‘‘dark
matter’’ without functional deﬁnitions. The full interpretation
should include all sequence elements of a genome. On the other
hand, we still do not have enough high-quality data for bio-
logical applications, such as in the case of cancer studies, where
only thousands of samples have been sequenced so far for the
most complicated disease threatening all members of our man-
kind on a daily basis. Most important for the ﬁeld of bioinfor-
matics is that as more high-quality data are generated, we
apparently are stepping into the ‘‘Big Data Era’’. Therefore,we need to raise the bar higher for better data and more
sophisticated tools. Genomics, Proteomics & Bioinformatics
(GPB) is apparently doing its job by evaluating the existing
databases, algorithms, and toolkits (see related articles in this
and the upcoming issues). Through summarizing the quotation
and unique features of the databases and tools, the authors are
trying to provide users clear ideas as to what may be the best to
use and tool developers as the right directions for new initia-
tives. For instance, biological networks, which are time-depen-
dent and non-linear, have to be built with full participation of
the relevant parties –– not only proteins and enzymes but also
RNA molecules that are truly involved in cellular complexes
for appropriate functions. As a ﬁnal note, we would like to
see some consolidations where the current bioinformatic
resources are organized by applications, ranked based on user
feedbacks, and evaluations by all users.Completing interests
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